Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??
Operating segment net revenue, operating income (loss) and income (loss) before taxes for each of the years ended May 31 were as follows:

2007
2006
2005
Net revenue:
SSDI
$
558,484
$
-
$
-
All other
80,300
10,309,709
2,982,586
Total net revenue
$
638,784
$
10,309,709
$
2,982,586
Operating income (loss):
SSDI
$
(176,432
)
$
-
$
-
All other
(14,587,407
)
3,911,640
87,421
Total operating income (loss)
$
(14,763,839
)
$
3,911,640
$
87,421
Income (loss) before taxes:
SSDI
$
(169,913
)
$
-
$
-
All other
34,616,133
28,672,688
(10,518,704
)
Total income (loss) before taxes
$
34,446,220
$
28,672,688
$
(10,518,704
)

Income/loss before taxes of $169,913. You've got to look at the bottom line, not just selected numbers. I'm not arguing that Holocom isn't or won't be a good investment. I just didn't think it was accurate for greeneyes to say we've already recouped most of our investment. This is far from the case. So far we've invested $700k and also set up a credit line of I think $590k for our Holocom related investments. We have yet to receive anything back on this investment. I DO believe this will pay off in the future.
Share
New Message
Please login to post a reply